NCT01759264View on ClinicalTrials.gov

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Crohn's Disease
All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01759264 - An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR) | Biotech Hunter | Biotech Hunter